IShares Global Financial Statements From 2010 to 2024

XHC Etf  CAD 70.58  0.40  0.57%   
IShares Global financial statements provide useful quarterly and yearly information to potential iShares Global Healthcare investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on IShares Global financial statements helps investors assess IShares Global's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting IShares Global's valuation are summarized below:
iShares Global Healthcare does not presently have any fundamental trends for analysis.
Check IShares Global financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IShares Global's main balance sheet or income statement drivers, such as , as well as many indicators such as . IShares financial statements analysis is a perfect complement when working with IShares Global Valuation or Volatility modules.
  
This module can also supplement various IShares Global Technical models . Check out the analysis of IShares Global Correlation against competitors.

iShares Global Healthcare ETF Beta Analysis

IShares Global's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current IShares Global Beta

    
  0.71  
Most of IShares Global's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iShares Global Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, iShares Global Healthcare has a Beta of 0.71. This is much higher than that of the iShares family and significantly higher than that of the Sector Equity category. The beta for all Canada etfs is notably lower than that of the firm.

About IShares Global Financial Statements

IShares Global investors utilize fundamental indicators, such as revenue or net income, to predict how IShares Etf might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
The investment seeks to replicate, net of expenses, the performance of the SP Global 1200 Health Care Sector Canadian Dollar Hedged index. iSHARES GLOBAL is traded on Toronto Stock Exchange in Canada.

Pair Trading with IShares Global

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IShares Global position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Global will appreciate offsetting losses from the drop in the long position's value.

Moving together with IShares Etf

  0.95ZUH BMO Equal WeightPairCorr

Moving against IShares Etf

  0.87XIT iShares SPTSX CappedPairCorr
  0.85TEC TD Global TechnologyPairCorr
  0.85XIU iShares SPTSX 60PairCorr
  0.85ZSP BMO SP 500PairCorr
  0.85VFV Vanguard SP 500PairCorr
The ability to find closely correlated positions to IShares Global could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IShares Global when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IShares Global - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling iShares Global Healthcare to buy it.
The correlation of IShares Global is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IShares Global moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if iShares Global Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IShares Global can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether iShares Global Healthcare is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if IShares Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ishares Global Healthcare Etf. Highlighted below are key reports to facilitate an investment decision about Ishares Global Healthcare Etf:
Check out the analysis of IShares Global Correlation against competitors.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Please note, there is a significant difference between IShares Global's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Global is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Global's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.